PortfoliosLab logoPortfoliosLab logo
MRK vs. CB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MRK vs. CB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck & Co., Inc. (MRK) and Chubb Limited (CB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MRK achieves a 14.39% return, which is significantly higher than CB's 3.43% return. Both investments have delivered pretty close results over the past 10 years, with MRK having a 11.61% annualized return and CB not far ahead at 11.89%.


MRK

1D
-1.05%
1M
7.31%
YTD
14.39%
6M
22.75%
1Y
56.85%
3Y*
5.78%
5Y*
13.57%
10Y*
11.61%

CB

1D
-1.35%
1M
0.70%
YTD
3.43%
6M
8.96%
1Y
10.97%
3Y*
20.64%
5Y*
15.72%
10Y*
11.89%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MRK vs. CB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MRK
Merck & Co., Inc.
14.39%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%
CB
Chubb Limited
3.43%14.46%23.89%4.20%15.97%27.85%1.41%22.94%-9.63%12.82%

Correlation

The correlation between MRK and CB is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Mar 24, 1993

0.31

Fundamentals

Market Cap

MRK:

$295.45B

CB:

$127.01B

EPS

MRK:

$3.58

CB:

$28.35

PE Ratio

MRK:

33.34

CB:

11.35

PEG Ratio

MRK:

0.03

CB:

0.79

PS Ratio

MRK:

4.54

CB:

2.67

PB Ratio

MRK:

6.44

CB:

1.59

Total Revenue (TTM)

MRK:

$65.59B

CB:

$48.15B

Gross Profit (TTM)

MRK:

$49.79B

CB:

$17.01B

EBITDA (TTM)

MRK:

$22.69B

CB:

$12.22B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MRK vs. CB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRK
MRK Risk / Return Rank: 9090
Overall Rank
MRK Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 9090
Sortino Ratio Rank
MRK Omega Ratio Rank: 8686
Omega Ratio Rank
MRK Calmar Ratio Rank: 9292
Calmar Ratio Rank
MRK Martin Ratio Rank: 9191
Martin Ratio Rank

CB
CB Risk / Return Rank: 6161
Overall Rank
CB Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
CB Sortino Ratio Rank: 5555
Sortino Ratio Rank
CB Omega Ratio Rank: 5454
Omega Ratio Rank
CB Calmar Ratio Rank: 6565
Calmar Ratio Rank
CB Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRK vs. CB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Chubb Limited (CB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MRKCBDifference
Sharpe ratioReturn per unit of total volatility

+1.47

Sortino ratioReturn per unit of downside risk

+2.02

Omega ratioGain probability vs. loss probability

1.36

1.12

+0.24

Calmar ratioReturn relative to maximum drawdown

5.03

1.18

+3.85

Martin ratioReturn relative to average drawdown

12.59

2.70

+9.90

MRK vs. CB - Sharpe Ratio Comparison

The current MRK Sharpe Ratio is 2.10, which is higher than the CB Sharpe Ratio of 0.62. The chart below compares the historical Sharpe Ratios of MRK and CB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MRKCBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.10

0.62

+1.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.58

0.78

-0.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.51

0.50

0.00

Sharpe Ratio (All Time)

Calculated using the full available price history

0.48

0.40

+0.08

Drawdowns

MRK vs. CB - Drawdown Comparison

The maximum MRK drawdown since its inception was -68.61%, which is greater than CB's maximum drawdown of -50.99%. Use the drawdown chart below to compare losses from any high point for MRK and CB.


Loading charts...

Drawdown Indicators


MRKCBDifference

Max Drawdown

Largest peak-to-trough decline

-68.61%

-50.99%

-17.62%

Max Drawdown (1Y)

Largest decline over 1 year

-11.37%

-9.36%

-2.01%

Max Drawdown (3Y)

Largest decline over 3 years

-43.44%

-14.35%

-29.09%

Max Drawdown (5Y)

Largest decline over 5 years

-43.44%

-19.26%

-24.18%

Max Drawdown (10Y)

Largest decline over 10 years

-43.44%

-42.59%

-0.85%

Current Drawdown

Current decline from peak

-4.65%

-5.81%

+1.16%

Average Drawdown

Average peak-to-trough decline

-18.84%

-10.68%

-8.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

4.52%

+0.01%

Volatility

MRK vs. CB - Volatility Comparison

Merck & Co., Inc. (MRK) has a higher volatility of 9.44% compared to Chubb Limited (CB) at 6.11%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than CB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MRKCBDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.44%

6.11%

+3.33%

Volatility (6M)

Calculated over the trailing 6-month period

18.14%

13.14%

+5.00%

Volatility (1Y)

Calculated over the trailing 1-year period

27.30%

17.69%

+9.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.71%

20.34%

+3.37%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.96%

23.69%

-0.73%

Dividends

MRK vs. CB - Dividend Comparison

MRK's dividend yield for the trailing twelve months is around 2.78%, more than CB's 1.21% yield.


PositionTTM20252024202320222021202020192018201720162015
CB
Chubb Limited
1.21%1.22%1.30%1.51%1.49%1.65%2.01%1.91%2.24%1.93%2.07%4.23%
MRK
Merck & Co., Inc.
2.78%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

MRK vs. CB - Financials Comparison

This section allows you to compare key financial metrics between Merck & Co., Inc. and Chubb Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
16.29B
1.88B
(MRK) Total Revenue
(CB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


MRK and CB have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MRK has higher volatility (9.44%) compared to CB (6.11%). In terms of maximum drawdown, MRK dropped -68.61% vs CB's -50.99%.

MRK currently has the higher Sharpe Ratio (2.10 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MRK and CB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer